These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8702689)

  • 1. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
    Kenner KA; Anyanwu E; Olefsky JM; Kusari J
    J Biol Chem; 1996 Aug; 271(33):19810-6. PubMed ID: 8702689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin.
    Bandyopadhyay D; Kusari A; Kenner KA; Liu F; Chernoff J; Gustafson TA; Kusari J
    J Biol Chem; 1997 Jan; 272(3):1639-45. PubMed ID: 8999839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I.
    Kenner KA; Hill DE; Olefsky JM; Kusari J
    J Biol Chem; 1993 Dec; 268(34):25455-62. PubMed ID: 8244979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
    Zhang WR; Li PM; Oswald MA; Goldstein BJ
    Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.
    Dadke SS; Li HC; Kusari AB; Begum N; Kusari J
    Biochem Biophys Res Commun; 2000 Aug; 274(3):583-9. PubMed ID: 10924321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.
    Hashimoto N; Zhang WR; Goldstein BJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):569-76. PubMed ID: 1599438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities.
    Maegawa H; Ide R; Hasegawa M; Ugi S; Egawa K; Iwanishi M; Kikkawa R; Shigeta Y; Kashiwagi A
    J Biol Chem; 1995 Mar; 270(13):7724-30. PubMed ID: 7535776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.
    Kole HK; Smyth MS; Russ PL; Burke TR
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):1025-31. PubMed ID: 7487920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase.
    Way BA; Mooney RA
    J Biol Chem; 1993 Dec; 268(35):26409-15. PubMed ID: 8253766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3'-kinase activity via modulation of phosphorylation of insulin receptor substrate-1.
    Ugi S; Maegawa H; Kashiwagi A; Adachi M; Olefsky JM; Kikkawa R
    J Biol Chem; 1996 May; 271(21):12595-602. PubMed ID: 8647870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
    Ricort JM; Binoux M
    J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two nonradioactive assays for phosphotyrosine phosphatases with activity toward the insulin receptor.
    Madden JA; Bird MI; Man Y; Raven T; Myles DD
    Anal Biochem; 1991 Dec; 199(2):210-5. PubMed ID: 1812786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
    Cicirelli MF; Tonks NK; Diltz CD; Weiel JE; Fischer EH; Krebs EG
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5514-8. PubMed ID: 2164686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s).
    Faure R; Baquiran G; Bergeron JJ; Posner BI
    J Biol Chem; 1992 Jun; 267(16):11215-21. PubMed ID: 1375938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60c-src activity.
    Way BA; Mooney RA
    Mol Cell Biochem; 1994 Oct; 139(2):167-75. PubMed ID: 7532275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.
    Byon JC; Kusari AB; Kusari J
    Mol Cell Biochem; 1998 May; 182(1-2):101-8. PubMed ID: 9609119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
    Meyerovitch J; Backer JM; Kahn CR
    J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor.
    Dadke S; Kusari A; Kusari J
    Mol Cell Biochem; 2001 May; 221(1-2):147-54. PubMed ID: 11506178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.